What is the share price of Zenith Healthcare Ltd (ZENITHHE) today?
The share price of ZENITHHE as on 22nd September 2026 is ₹3.26. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Zenith Healthcare Ltd (ZENITHHE) share?
The past returns of Zenith Healthcare Ltd (ZENITHHE) share are- Past 1 week: 5.16%
- Past 1 month: 7.95%
- Past 3 months: 3.48%
- Past 6 months: 10.85%
- Past 1 year: -24.65%
- Past 3 years: -19.26%
- Past 5 years: -53.55%
What are the peers or stocks similar to Zenith Healthcare Ltd (ZENITHHE)?
The peers or stocks similar to Zenith Healthcare Ltd (ZENITHHE) include:What is the market cap of Zenith Healthcare Ltd (ZENITHHE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zenith Healthcare Ltd (ZENITHHE) is ₹17.57 Cr as of 22nd September 2026.What is the 52 week high and low of Zenith Healthcare Ltd (ZENITHHE) share?
The 52-week high of Zenith Healthcare Ltd (ZENITHHE) is ₹4.40 and the 52-week low is ₹2.23.What is the PE and PB ratio of Zenith Healthcare Ltd (ZENITHHE) stock?
The P/E (price-to-earnings) ratio of Zenith Healthcare Ltd (ZENITHHE) is -1757.27. The P/B (price-to-book) ratio is 2.37.Which sector does Zenith Healthcare Ltd (ZENITHHE) belong to?
Zenith Healthcare Ltd (ZENITHHE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Zenith Healthcare Ltd (ZENITHHE) shares?
You can directly buy Zenith Healthcare Ltd (ZENITHHE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Zenith Healthcare Ltd
ZENITHHE Share Price
BSEZENITHHE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ZENITHHE Performance & Key Metrics
ZENITHHE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 103.37 | 2.37 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.38 | 5.94 | 0.48% |
ZENITHHE Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
ZENITHHE Company Profile
Zenith Healthcare Limited is an integrated pharmaceutical company in India, manufacturing various pharmaceutical formulations and offering contract manufacturing across multiple therapeutic areas.
ZENITHHE Forecast
ZENITHHE Forecasts
ZENITHHE
ZENITHHE
Income
Balance Sheet
Cash Flow
ZENITHHE Income Statement
ZENITHHE Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.18 | 2.65 | 3.11 | 2.47 | 3.53 | 3.32 | 2.38 | 2.53 | 2.72 | 3.50 | ||||||||||
| Operating & Other expenses | 3.31 | 2.45 | 2.88 | 2.50 | 3.40 | 3.28 | 2.09 | 2.21 | 3.08 | 3.26 | ||||||||||
| EBITDA | -0.13 | 0.20 | 0.23 | -0.03 | 0.13 | 0.04 | 0.29 | 0.32 | -0.36 | 0.24 | ||||||||||
| Depreciation/Amortization | 0.05 | 0.04 | 0.04 | 0.07 | 0.08 | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 | ||||||||||
| PBIT | -0.18 | 0.16 | 0.19 | -0.10 | 0.05 | -0.02 | 0.22 | 0.25 | -0.42 | 0.18 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -0.18 | 0.16 | 0.19 | -0.10 | 0.05 | -0.02 | 0.22 | 0.25 | -0.42 | 0.18 | ||||||||||
| Taxes & Other Items | 0.07 | 0.00 | 0.08 | 0.19 | -0.06 | -0.01 | 0.08 | 0.02 | -0.08 | 0.04 | ||||||||||
| Net Income | -0.25 | 0.16 | 0.11 | -0.29 | 0.11 | -0.01 | 0.14 | 0.23 | -0.34 | 0.14 | ||||||||||
| EPS | -0.05 | 0.03 | 0.02 | -0.05 | 0.02 | 0.00 | 0.03 | 0.04 | -0.06 | 0.03 |
ZENITHHE Company Updates
ZENITHHE Stock Peers
ZENITHHE Past Performance & Peer Comparison
ZENITHHE Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Zenith Healthcare Ltd | -1,757.27 | 2.37 | — |
| Sun Pharmaceutical Industries Ltd | 38.59 | 5.28 | 0.87% |
| Torrent Pharmaceuticals Ltd | 86.77 | 10.67 | 0.69% |
| Zydus Lifesciences Ltd | 23.00 | 3.92 | 0.09% |
ZENITHHE Stock Price Comparison
Compare ZENITHHE with any stock or ETFZENITHHE Holdings
ZENITHHE Shareholdings
ZENITHHE Promoter Holdings Trend
ZENITHHE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
ZENITHHE Institutional Holdings Trend
ZENITHHE Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
ZENITHHE Shareholding Pattern
ZENITHHE Shareholding Pattern
ZENITHHE Shareholding History
ZENITHHE Shareholding History
smallcases containing ZENITHHE stock
smallcases containing ZENITHHE stock
Looks like this stock is not in any smallcase yet.
ZENITHHE Events
ZENITHHE Events
ZENITHHE Dividend Trend
ZENITHHE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
ZENITHHE Dividend Trend
ZENITHHE has not given any dividends in last 5 years
ZENITHHE Dividends
ZENITHHE Dividends
ZENITHHE Stock News & Opinions
ZENITHHE Stock News & Opinions
Zenith Healthcare Limited informed the BSE Limited that Mr. Akshit M. Raycha (DIN: 03039859) has been regularized as Joint Managing Director/Whole Time Director at the company's 32nd Annual General Meeting via a special resolution. The appointment, initially made on May 29, 2026, will continue until the conclusion of the next AGM, with a monthly remuneration of up to Rs 200,000, potentially increasing by Rs 900,000 per annum.
Zenith Healthcare Limited announced that Mr. Mahendra C. Raycha has been re-appointed as Managing Director for another three-year term, from July 1, 2026, to June 30, 2029, following a special resolution at the company’s 32nd Annual General Meeting. Mr. Raycha, who holds 6,604,000 equity shares, representing 12.29% voting power, was re-appointed due to attaining the age of 70 years, and his continued experience is deemed vital for the company's future growth.
Zenith Healthcare Limited will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Ltd. The trading window for securities of the company will remain closed until 48 hours after the financial results are declared.
Zenith Healthcare Limited informed the Bombay Stock Exchange that its board of directors approved the notice of the Annual General Meeting (AGM) and director's report, scheduling the AGM for August 28, 2026, via video conferencing and other audio-visual means. The company has fixed August 21, 2026, as the record date for the AGM, with the register of members closed from August 22 to August 28, 2026. Additionally, the board recommended the reappointment of Mr. Mahendra C Raycha as Chairman and Managing Director for a further three-year term, effective July 1, 2026, at a monthly remuneration of Rs 200,000, subject to shareholder approval via a special resolution.
Zenith Healthcare Limited informed the Bombay Stock Exchange that its board of directors approved the notice of the Annual General Meeting (AGM) and director's report, scheduling the AGM for August 28, 2026, via video conferencing and other audio-visual means. The company has fixed August 21, 2026, as the record date for the AGM, with the register of members closed from August 22, 2026, to August 28, 2026. Additionally, the board recommended the reappointment of Mr. Mahendra C Raycha as Chairman and Managing Director for a further three-year term, effective July 1, 2026, at a monthly remuneration of Rs 200,000, subject to shareholder approval via a special resolution.
Zenith Healthcare Limited informed the Bombay Stock Exchange that its book closure will be from August 22, 2026, to August 28, 2026, with a record date of August 21, 2026, for the 32nd Annual General Meeting (AGM) for the financial year 2025-2026.
Net loss of Zenith Health Care reported to Rs 0.34 crore in the quarter ended March 2026 as against net profit of Rs 0.11 crore during the previous quarter ended March 2025. Sales declined 23.62% to Rs 2.62 crore in the quarter ended March 2026 as against Rs 3.43 crore during the previous quarter ended March 2025. For the full year,net profit declined 85.71% to Rs 0.01 crore in the year ended March 2026 as against Rs 0.07 crore during the previous year ended March 2025. Sales declined 7.15% to Rs 10.52 crore in the year ended March 2026 as against Rs 11.33 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2.623.43 -24 10.5211.33 -7 OPM %-17.560.58 --1.050.88 - PBDT-0.360.13 PL 0.290.52 -44 PBT-0.420.05 PL 0.030.29 -90 NP-0.340.11 PL 0.010.07 -86 Powered by Capital Market - Live
Zenith Health Care will hold a meeting of the Board of Directors of the Company on 29 May 2026.
Net profit of Zenith Health Care reported to Rs 0.22 crore in the quarter ended December 2025 as against net loss of Rs 0.29 crore during the previous quarter ended December 2024. Sales rose 7.36% to Rs 2.48 crore in the quarter ended December 2025 as against Rs 2.31 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2.482.31 7 OPM %10.89-8.23 - PBDT0.31-0.03 LP PBT0.24-0.10 LP NP0.22-0.29 LP Powered by Capital Market - Live
Zenith Health Care will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -5.1%, vs industry avg of 11.76%
Over the last 5 years, market share stayed at 0%